AIFF vs. EGAN, ARBE, AISP, SIFY, TRUE, ISSC, SVCO, CMCM, CDLX, and RMBL
Should you be buying Firefly Neuroscience stock or one of its competitors? The main competitors of Firefly Neuroscience include eGain (EGAN), Arbe Robotics (ARBE), Airship AI (AISP), Sify Technologies (SIFY), TrueCar (TRUE), Innovative Solutions and Support (ISSC), Silvaco Group (SVCO), Cheetah Mobile (CMCM), Cardlytics (CDLX), and RumbleOn (RMBL). These companies are all part of the "computer software" industry.
Firefly Neuroscience vs.
Firefly Neuroscience (NASDAQ:AIFF) and eGain (NASDAQ:EGAN) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment.
eGain received 390 more outperform votes than Firefly Neuroscience when rated by MarketBeat users. Likewise, 69.52% of users gave eGain an outperform vote while only 0.00% of users gave Firefly Neuroscience an outperform vote.
eGain has a consensus target price of $8.50, indicating a potential upside of 51.92%. Given eGain's stronger consensus rating and higher probable upside, analysts plainly believe eGain is more favorable than Firefly Neuroscience.
In the previous week, eGain had 6 more articles in the media than Firefly Neuroscience. MarketBeat recorded 6 mentions for eGain and 0 mentions for Firefly Neuroscience. eGain's average media sentiment score of 0.79 beat Firefly Neuroscience's score of -0.95 indicating that eGain is being referred to more favorably in the news media.
Firefly Neuroscience has a beta of 3.22, meaning that its share price is 222% more volatile than the S&P 500. Comparatively, eGain has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500.
5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 53.9% of eGain shares are owned by institutional investors. 8.4% of Firefly Neuroscience shares are owned by insiders. Comparatively, 37.7% of eGain shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
eGain has a net margin of 4.86% compared to Firefly Neuroscience's net margin of -73.72%. eGain's return on equity of 7.41% beat Firefly Neuroscience's return on equity.
eGain has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than eGain, indicating that it is currently the more affordable of the two stocks.
Summary
eGain beats Firefly Neuroscience on 16 of the 18 factors compared between the two stocks.
Get Firefly Neuroscience News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIFF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Firefly Neuroscience Competitors List
Related Companies and Tools
This page (NASDAQ:AIFF) was last updated on 5/22/2025 by MarketBeat.com Staff
